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LEGISLATION AND GENETIC DISCRIMINATION 
SHARONA HOFFMAN1 
 
I will be talking about the laws that address genetic discrimination, and there is quite 
a variety of them.  Let me begin with state laws. 
I.  STATE LEGISLATION 
State legislation addresses genetic discrimination in both employment and health 
insurance.  Thirty-one states have passed laws that address genetic discrimination in 
employment.  Approximately thirteen states prohibit employers from requiring 
applicants to undergo genetic testing as a condition of employment.  Some states 
have more limited restrictions.  Florida prohibits only the screening of applicants for 
the sickle-cell trait.  Wisconsin requires employers to obtain written and informed 
consent from applicants prior to administering genetic tests, but does not preclude 
their utilization altogether.  Some states establish exceptions that permit genetic 
testing that is job-related or that is conducted, with the employee’s written and 
informed consent, for the purpose of investigating Workers’ Compensation claims or 
to protect the employee’s health by testing for potential work-related medical 
problems. 
Some employees actually wish to undergo genetic testing to determine if they 
have genetic conditions such as chronic berrylium disease, which is triggered by 
exposure to toxins in the workplace.  I have read that a few employees have filed 
claims against their employers for not conducting this kind of genetic testing.  The 
issue of genetic testing can therefore be a “catch 22” for employers.  Many 
employees will be upset if the employer subjects them to genetic tests because they 
believe the tests constitute an invasion of privacy.  Others, however, will accuse the 
employer of misconduct if the employer does not offer genetic testing that will detect 
susceptibility to a condition that is triggered by a known substance in the workplace. 
Let us turn to health insurance.  As of 1999, over half the states had enacted laws 
prohibiting health insurance companies from requiring genetic testing as a condition 
of coverage or from denying insurance or charging higher rates based upon the 
results of genetic tests.  Again, the statutes vary in their breadth and scope.  The 
Texas statute, for example, applies only to group health benefits plans and not to 
individual health insurance policies.  The Alabama statute pertains only to genetic 
tests for cancer. 
Even the statutes that address the discriminatory use of all genetic test results 
may leave many individuals unprotected.  One problem that drafting legislation 
presents is the challenge of crafting language that is precise enough to be sufficiently 
inclusive.  This is particularly difficult when it comes to discussing new technology, 
such as genetic testing.  “Genetic test” is typically defined as “A laboratory test of 
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human chromosomes or DNA that is used to identify the presence or absence of 
inherited or congenital alterations in genetic material that are associated with disease 
or illness.”  Under this definition, an insurer would violate the law if it discriminated 
against an individual based on a physical DNA test, but not if it discriminated based 
on a family history of genetic abnormalities, such as a parent’s death from 
Huntington’s disease.  A better, more inclusive approach is to prohibit discrimination 
based on any “genetic information,” which would include information derived from 
family histories.  A few states have adopted this approach, and in the employment 
arena, several states specifically prohibit employers from attaining genetic data 
concerning the applicant’s family members. 
The state laws are largely inconsistent in their scope, and therefore, the degree of 
protection one enjoys may depend on the state of one’s residence.  Another 
limitation of the state statutes is that they do not apply to self-funded employer plans.  
Under the Employee Retirement Security Act of 1974 (ERISA),2 state laws 
regulating health insurance, including those that prohibit discrimination, are 
preempted by ERISA insofar as they apply to self-funded employee benefit plans. 
An increasing number of employers, especially large employers, are self-insured.  
Employees who obtain insurance through these self-insured employers are not 
protected by the state laws that prohibit genetic discrimination.  Consequently, the 
regulation of insurers’ use of genetic information cannot be left to the states alone. 
II.  HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT (HIPAA) 
Significant protection is provided by the Health Insurance Portability and 
Accountability Act of 1996 (HIPAA).3  HIPAA mandates that group health plans 
may not establish rules for enrollment eligibility based on “genetic information.”  So, 
for example, if there is a group seeking health insurance, the insurer cannot refuse to 
insure particular members of the group because of genetic information. 
HIPAA also requires that all group health plans limit to no more than twelve 
months their period of excluded coverage for pre-existing conditions; that is, 
conditions for which medical advice, diagnosis, care, or treatment was recommended 
or received in the prior six months.  HIPAA provides, however, that genetic 
information may not be considered a preexisting condition “in the absence of a 
diagnosis of the condition relating to such information.”  Thus, a woman who 
undergoes genetic testing and tests positive for BRCA1,4 which indicates that she is 
at an increased risk of breast cancer, may not be excluded from coverage for breast 
cancer for any period of time unless she has actually been diagnosed with the 
disease.  These mandates, however, apply only to group health plans and therefore 
do not protect the 10 to 15 percent of the insured who have individual policies. 
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III.  AMERICANS WITH DISABILITIES ACT (ADA) 
The second federal law that is relevant to the issue of genetic discrimination is 
the Americans with Disabilities Act (ADA).5  The ADA prohibits employers from 
discriminating against qualified individuals with disabilities with respect to a variety 
of employment activities, such as hiring, promotion, firing, and benefits of 
employment, including insurance.  Employers cannot refuse to hire or fire someone 
because of her disability, and they cannot provide inferior insurance benefits or no 
benefits to an individual because she has a disability.  So, the question is: Does the 
ADA protect people who don’t have a disability but who have a genetic abnormality 
that might lead to a disability in the future? 
The ADA covers individuals who have a “physical or mental impairment that 
substantially limits one or more of [their] major life activities.”6  This provision does 
not apply to discrimination based solely on the results of a genetic test.  Someone 
who is asymptomatic but tests positive for the BRCA1 abnormality and therefore has 
over a 50 percent chance of developing breast cancer in the future is not currently an 
individual with an actual disability.  The ADA also protects those who have a 
“record of” a disability.7  This is also inapplicable to an asymptomatic person who 
tests positive for the BRCA1 abnormality, because she has not developed the disease 
and therefore has no record of suffering from a disability.  Finally, the ADA protects 
individuals who don’t have a disability but who are incorrectly “regarded as” having 
a disability, and this is the most relevant category for our purposes.8 
In March of 1995, the Equal Employment Opportunity Commission (EEOC) 
issued interpretive guidance regarding the ADA that addressed the issue of genetic 
discrimination.9  According to the EEOC, employers that discriminate against 
individuals based upon genetic information are “regarding” the employees as having 
a disability, and their acts of discrimination constitute violations of the ADA.10  
Thus, according to the EEOC, employers who provide health insurance benefits to 
their employees may not deny such benefits to individuals or charge them higher 
premiums based upon genetic data. 
Unfortunately, I think this might be a bit of a stretch, and the guidance has not 
yet been tested in court.  If an employer refuses to hire someone who tests positive 
for BRCA1 or refuses to provide her with health insurance, the employer isn’t 
regarding her as having a disability.  Rather, the employer is regarding her only as 
having a high likelihood of developing an illness at some time in the future.  It 
should also be noted that breast cancer is not necessarily a disability, according to the 
courts.  Some courts have ruled that it is a serious illness but not a “disability,” 
especially if it goes into remission quickly after treatment with surgery or surgery 
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and a short course of radiation therapy.  Some genetic tests, therefore, will identify 
susceptibilities to illness that are not necessarily disabilities covered by the ADA.  It 
is difficult to argue that an individual should benefit from statutory protection 
stemming from a genetically-based prediction that she is likely to develop a disease, 
even though she would not be covered by the ADA if she actually had the illness in 
question.  Consequently, I do not think that the EEOC’s interpretation of the ADA 
will withstand judicial scrutiny. 
There has been one case filed by the EEOC involving a challenge to genetic 
testing under the ADA.  On February 9, 2001, the EEOC sued Burlington North 
Santa Fe Railroad, charging that the railroad violated the ADA by requiring 
employees who filed claims for work-related carpal tunnel syndrome to provide 
blood samples in order to determine whether they had a genetic susceptibility to the 
condition.  Presumably, if they were genetically susceptible to the disease, it would 
not be a work-related injury, and the railroad would not have to pay the claim.  On 
February 12, 2001, the defendant announced that it would voluntarily stop 
conducting the genetic tests, and the matter settled in April of 2001, so no court 
opinion was issued in the case. 
IV.  EXECUTIVE ORDER 
Federal employees enjoy stronger protection against genetic discrimination than 
do most other Americans.  On February 8, 2000, President Clinton issued Executive 
Order No. 13145, “To Prohibit Discrimination in Federal Employment Based on 
Genetic Information.”  The executive order precludes federal employers from 
requesting, requiring, collecting or purchasing genetic information from applicants 
and employees.  An exception to the general rule allows for the genetic testing of 
applicants if the obtained information is to be used exclusively to determine whether 
further evaluation is needed to diagnose a current medical condition that could 
prevent the applicant from performing essential job functions.  Only federal 
employees are covered by the executive order.11 
V.  PROPOSED FEDERAL LEGISLATION 
I have tried to show that neither state legislation nor existing federal law provides 
comprehensive protection to the American public against genetic discrimination.  
Consequently, if we are serious about addressing the issue, we will need new federal 
legislation that will create a national mandate concerning genetic discrimination.  
Numerous bills have in fact been introduced in Congress during the past few years, 
though none has yet become law. 
The first bill that Senator Thomas Daschle promoted after he became Minority 
Leader in June of 2001 was his “Genetic Non-discrimination in Health Insurance and 
Employment Act.”12  The bill would prohibit employers from using genetic 
information in hiring new employees or in determining promotions, salary and 
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benefits.13  It would also bar all insurers from raising premiums or denying coverage 
because of genetic test results.14 
The Patient’s Bill of Rights that was passed by the Senate on June 29, 2001, 
contained a last-minute amendment that would prohibit health insurers from 
restricting enrollment or raising premium rates based on an individual’s genetic 
information.15  In addition, President Bush pledged his support for banning genetic 
discrimination by employers and insurers during a radio address in June, 2001.16 
In light of the accomplishments of the Human Genome Project, the issue of 
genetic discrimination has raised significant concern in academic and legislative 
circles and has generated considerable media attention.  Given the public’s repeated 
and vocal cries for action, I think it is quite likely that Congress will pass an anti-
discrimination mandate in the not too distant future. 
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